Ring B Z, Cordes S P, Overbeek P A, Barsh G S
Department of Pediatrics, Howard Hughes Medical Institute, Stanford, California 94305-5428, USA.
Development. 2000 Jan;127(2):307-17. doi: 10.1242/dev.127.2.307.
Maf is a basic domain/leucine zipper domain protein originally identified as a proto-oncogene whose consensus target site in vitro, the T-MARE, is an extended version of an AP-1 site normally recognized by Fos and Jun. Maf and the closely related family members Neural retina leucine zipper (Nrl), L-Maf, and Krml1/MafB have been implicated in a wide variety of developmental and physiologic roles; however, mutations in vivo have been described only for Krml1/MafB, in which a loss-of-function causes abnormalities in hindbrain development due to failure to activate the Hoxa3 and Hoxb3 genes. We have used gene targeting to replace Maf coding sequences with those of lacZ, and have carried out a comprehensive analysis of embryonic expression and the homozygous mutant phenotype in the eye. Maf is expressed in the lens vesicle after invagination, and becomes highly upregulated in the equatorial zone, the site at which self-renewing anterior epithelial cells withdraw from the cell cycle and terminally differentiate into posterior fiber cells. Posterior lens cells in Maf(lacZ) mutant mice exhibit failure of elongation at embryonic day 11.5, do not express (&agr;)A- and all of the (beta)-crystallin genes, and display inappropriately high levels of DNA synthesis. This phenotype partially overlaps with those reported for gene targeting of Prox1 and Sox1; however, expression of these genes is grossly normal, as is expression of Eya1, Eya2, Pax6, and Sox2. Recombinant Maf protein binds to T-MARE sites in the (alpha)A-, (beta)B2-, and (beta)A4-crystallin promoters but fails to bind to a point mutation in the (alpha)A-crystallin promoter that has been shown previously to be required for promoter function. Our results indicate that Maf directly activates many if not all of the (beta)-crystallin genes, and suggest a model for coordinating cell cycle withdrawal with terminal differentiation.
Maf是一种基本结构域/亮氨酸拉链结构域蛋白,最初被鉴定为原癌基因,其体外共有靶位点T-MARE是Fos和Jun通常识别的AP-1位点的扩展形式。Maf以及与之密切相关的家族成员神经视网膜亮氨酸拉链(Nrl)、L-Maf和Krml1/MafB参与了多种发育和生理功能;然而,体内突变仅在Krml1/MafB中被描述,其功能丧失会导致后脑发育异常,原因是无法激活Hoxa3和Hoxb3基因。我们利用基因打靶技术用lacZ的编码序列替换Maf的编码序列,并对眼睛中的胚胎表达和纯合突变体表型进行了全面分析。Maf在晶状体泡内陷后表达,并在赤道区高度上调,赤道区是自我更新的前上皮细胞退出细胞周期并终末分化为后纤维细胞的部位。Maf(lacZ)突变小鼠的晶状体后细胞在胚胎第11.5天表现出伸长失败,不表达αA-和所有β-晶状体蛋白基因,并显示出DNA合成水平异常高。这种表型与Prox1和Sox1基因打靶报道的表型部分重叠;然而,这些基因的表达基本正常,Eya1、Eya2、Pax6和Sox2的表达也是如此。重组Maf蛋白与αA-、βB2-和βA4-晶状体蛋白启动子中的T-MARE位点结合,但不能与αA-晶状体蛋白启动子中的一个点突变结合,该点突变先前已被证明是启动子功能所必需的。我们的结果表明,Maf直接激活许多(如果不是全部)β-晶状体蛋白基因,并提出了一个协调细胞周期退出与终末分化的模型。